DD - DuPont de Nemours, Inc.

NYSE - NYSE Delayed Price. Currency in USD
-0.33 (-0.44%)
At close: 4:00PM EDT

75.03 +0.30 (0.40%)
Pre-Market: 8:31AM EDT

Stock chart is not supported by your current browser
Previous Close75.08
Bid74.00 x 800
Ask76.00 x 800
Day's Range74.27 - 75.48
52 Week Range17.84 - 102.38
Avg. Volume7,359,277
Market Cap55.875B
Beta (3Y Monthly)1.38
PE Ratio (TTM)17.65
EPS (TTM)4.24
Earnings DateN/A
Forward Dividend & Yield3.84 (4.19%)
Ex-Dividend Date2019-04-25
1y Target Est106.10
Trade prices are not sourced from all markets
  • If You Can Get a Handle on the Business, Dow Stock Is Worth Owning

    If You Can Get a Handle on the Business, Dow Stock Is Worth Owning

    The complicated thing about Dow (NYSE:DOW) is that keeping track of the business can be a little difficult. Understanding how its vast interests work together to drive Dow stock is even a little trickier. It might be best to begin with a brief history. Source: Roy Luck via Flickr (modified)Once upon a time, the Bronfmans, a wealthy Canadian family, owned 24% of Dupont. They got that stake as a result of its failed takeover of Conoco Oil in 1981. At the time, the Bronfman's most significant investment was its ownership of 36% of Seagram, the liquor company Sam Bronfman founded in 1928. The Dupont dividends generated by the 24% stake in the chemical company accounted for around 70% of Seagram's earnings. In a much-disputed decision, Seagram sold the DuPont stake in 2003, setting off a chain of events that would cost the Bronfmans billions.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 The Final PictureFast forward to June 3. Corteva (NYSE:CTVA), the agricultural segment of the old DowDupont was separated from DuPont (NYSE:DD), a global specialty chemicals company, while the material science unit was spun-off from DowDuPont on April 1 as DOW. I mention the Bronfmans because if they still had the 24% stake in DuPont, the past two years would have presented them with a lot of decisions.First, the August 31, 2017, a merger between the old Dow and DuPont saw shareholders receive 1.282 shares of DowDuPont per share held in DuPont. Throwing aside history, if the Bronfmans held on to the 24% stake, they would have received 267 million shares (867.8 million shares outstanding multiplied by 24% multiplied by 1.282) in the merged entity. If they chose to retain their 24% stake, they would have 89 million shares in DOW stock, 89 million shares in Corteeva, and 89 million shares in Dupont. Together, the trio of holdings has a market value of $13.4 billion with DuPont the largest holding valued at $6.6 billion followed by Dow at $4.6 billion and Corteva at $2.2 billion. They would pay annual dividends very close to $500 million. Which Would They Choose?In hindsight, I believe the family would choose to hang on to all three. Just the other day I was talking to a friend about the fact that four companies control the world seed market with Corteva being one of them. In 2018, it had $2.7 billion in adjusted EBITDA from $14.3 billion in annual revenue. Of the $14.3 billion in sales, approximately 56% was from its seeds and traits business with the rest from crop protection and pesticides. As the world continues to experience climate change, companies like Corteva will be vital to ensuring ongoing food supply. So, despite not paying a dividend, as an agricultural pureplay, Corteva is very attractive over the long haul. As for Dow and DuPont, they currently yield 5.4% and 2.3% respectively, making them very attractive dividend-paying stocks to also hold for the long haul.My InvestorPlace colleague Josh Enomoto recently suggested that DOW is still too complicated a company to understand despite being separated from DuPont and Corteva. He's not wrong. Dow's got a lot of moving parts operating in several different industries with seemingly little overlap and efficiencies. The Bottom Line on DOW StockI don't own any of the three stocks and I'm not sure I ever would. Not because I think any of them are bad businesses. It's just that I like to own easily understandable companies. Dow, DuPont, and Corteva aren't. That said, if the Bronfmans still were in the picture, I'd bet they would hang on to all three of them. I guess we'll never know. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 * 7 Value Stocks That Are Flying Under the Radar * 6 Mouth-Watering Fast Food Stocks for Growth Investors Compare Brokers The post If You Can Get a Handle on the Business, Dow Stock Is Worth Owning appeared first on InvestorPlace.

  • With or Without DuPont, DOW Stock Is Almost Too Complicated
    InvestorPlace7 days ago

    With or Without DuPont, DOW Stock Is Almost Too Complicated

    It wasn't a big surprise at all when chemical manufacturer Dow Inc (NYSE:DOW) split off from the organization formerly known as DowDuPont. Announced last year, the massive conglomerate would form three separate entities: DOW, DuPont (NYSE:DD) and Corteva (NYSE:CTVA). Moreover, the general consensus was that DOW stock, along with the other two names, would perform better individually.Source: Roy Luck via Flickr (modified)The principle idea behind this strategy is simple for anyone to appreciate. As a combined entity, DowDuPont was incredibly confusing and convoluted, similar to General Electric (NYSE:GE). And as you can tell from GE's technical chart, very few people today value large, aimless companies. The emphasis now is on agility, something that Dow Inc stock lacked when tethered to unrelated businesses like Corteva's agriculture.So far, though, that "untethering" thesis is on shaky ground. Sure, DOW stock is up nearly 8% in June. However, shares have crumbled since mid-April. Despite the strong start to the month, DOW is still about 14% shy of returning to its closing high.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy As They Hit 52-Week Lows However, optimists might note that Dow Inc stock suffered from the same pressures as everyone else; namely, geopolitical tensions with China. Of course, the situation currently looks terrible, with both sides not willing to concede an inch.That said, the smart money would eventually go toward a resolution between the No. 1 and No. 2 economies. After all, prolonged tensions do neither side any good.Additionally, the Trump administration's hard-nosed act could be just that, an act. It wouldn't be the first time that the President said one thing and did another. And if we did get that resolution, DOW stock would presumably jump higher.Still, I wouldn't get too excited about Dow Inc stock yet. DOW Stock Is a Complicated InvestmentA cute peculiarity of the DowDuPont breakup is that DOW stock replaced the former in the Dow Jones index. Thus, we have DOW in the Dow.Its inclusion also made sense because the venerable index maintains exposure to the materials sector. Fair enough. But increasingly, it's becoming clear that the markets don't favor big, complicated organizations with broad and disparate reach.We just need to look at the Dow Jones' recent history to confirm this sentiment. Dow Inc stock being listed into the index was the first shakeup since General Electric was kicked out. And what is General Electric but the mother of all complicated organizations?Sure, GE has slimmed down with its own divestments and spinoffs, but it's still confusing relative to modern organizations. I believe that's still the key risk associated with DOW stock.Because let's not overlook what's right in front of our face. Despite the much-covered DowDuPont breakup, Dow Inc stock doesn't provide a clean, linear path. Instead, the underlying company is stretched wide, featuring businesses in consumer products, packaging, industrial materials, large-scale infrastructures and technology.From a topical perspective, the separation into three entities streamlined operations for the individual cogs. Somewhat left out in the equation was that the individual cogs also have non-intuitive structures.Rather than a DOW in the Dow being a positive, it seems like an omen. That's because the Dow Jones has repeatedly kicked out or obstructed these yesteryear organizations. The ones that are still holding on are likely on their last leg.For instance, I thought a jack-of-all-trades company like 3M (NYSE:MMM) offered a contrarian play for its broad industry coverage. I was dead wrong. And I'm concerned the same fate awaits DOW stock: the markets just don't like these types of investments anymore. Don't Hold Your Breath on China or Even MexicoIn order to really see positive sentiment drive Dow Inc stock, speculators must hope for a big news item. A resolution to the U.S.-China trade war, along with normalizing relations with Mexico would do the trick.However, I wouldn't hold my breath on either event. First, I don't think the Chinese are really interested in a trade resolution. From day one, China sought to leapfrog the U.S. as the undisputed technological leader. That's why the Chinese committed brazen acts of corporate espionage. It's the quickest and dirtiest way to accomplish their goals. * 7 Dark Horse Stocks Winning the Race in 2019 Look at it this way: what would a trade deal imply for the Chinese? At the very least, it would mean that they must play by the rules. Ultimately, they'll never go for that because it necessarily means that China plays second fiddle to the U.S.As far as Mexico goes, a truce currently exists: Mexico agreed to impose tighter migrant controls in exchange for a tariff-free relationship with the U.S. But it's a very unsettling one, with Trump able to pull the plug if he doesn't like what he sees. My bet is that he doesn't. That also means we may not have a decisive catalyst for Dow stock for quite some time.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Buy As They Hit 52-Week Lows * 4 Antitrust Tech Stocks to Keep an Eye On * 5 Gold and Silver Stocks Touching Intraday Highs Compare Brokers The post With or Without DuPont, DOW Stock Is Almost Too Complicated appeared first on InvestorPlace.

  • Dow Inc. Stock Is The Best Bet of the Post-Split Bunch
    InvestorPlace8 days ago

    Dow Inc. Stock Is The Best Bet of the Post-Split Bunch

    Two years ago, Dupont and Dow Chemical merged to form Dow Dupont. Managements meant the union to be temporary so the recent split was not a surprise. But the transition did not go as smoothly for the new three stock entities. Today's writeup is to evaluate the Dow Inc (NYSE:DOW) prospects.Source: Shutterstock DOW stock corrected sharply in May, but that month was also rough for all equities -- it's not a sign of sustainable trouble ahead. So I don't take this drop as an omen for the company's future. The geopolitical and economic unrest, especially between the U.S. and China, put a few wrenches in everyone's plans.In its short new public independent life, DOW stock could be an opportunity. In theory, I would consider this as a speculative trade but with a twist.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Looking Deeper Into DOW StockDOW is still a mature set of businesses, just with a different umbrella. The future is not as unproven as, say, Beyond Meat (NYSE:BYND) or Tilray (NASDAQ:TLRY). Betting on DOW does not carry the same uncertainties as with other typical new stocks.Consensus is that the three spin-offs from Dow-DuPont will each be better on its own. Ultimately this was an elaborate bit of financial engineering.Now, Dow Inc. makes for a good bet for those investors who are looking for a fresh stock to invest in. The recent dip was a good opportunity to start but it still not too late. It doesn't carry the usual intrinsic risks that come with IPOs. * 7 Stocks to Buy As They Hit 52-Week Lows For the long term, there is no reason to wait for the perfect entry point. In the long run Dow Inc stock will be a winner along with the stock market. There will always be demand for its chemical products and services.For those who prefer to trade shorter term, there are important levels to watch for the next few weeks.$50 per share was important for the bulls to overtake. This was a pivot point that now serves as support for the more bullish action. Next, it is important for the DOW bulls to overcome the next challenge zone. The area around $52 per share has been pivotal since inception. Onus is on the bulls to retake it so they can use it as another base for the next leg higher.Specifically, above $51.70 DOW stock can target $54, which is another pivot point. The technical price pattern is unfolding in a predictable manner so it will be easy to track short term success. With the help of proper stops, active traders should do well with it.Conversely, there is an open gap below at $48 per share. Not every gap on stock charts closes, but nevertheless this is a concern -- especially if the negative geopolitical rhetoric deteriorates. If the corrective efforts restart, I expect supports at $49.50 per share.The bulls are breaking through descending trend line of lower highs. To that there is another opportunity to break another one around $53 per share. This is a moving target that changes with the price action but it's a lower high trend that will break and fuel more upside potential.Fundamentally DOW stock sells at 10 price to earnings ratio. This is cheap in relative and absolute terms. So owning Dow Inc. shares here is not likely to be a financial catastrophe, especially in the long run.Furthermore, the macroeconomic conditions still favor the bullish thesis for all stocks. As soon as this geopolitical unrest abates, the equities will set new all-time highs and DOW will benefit from it.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. Join his live chat room free here. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Buy As They Hit 52-Week Lows * 4 Antitrust Tech Stocks to Keep an Eye On * 5 Gold and Silver Stocks Touching Intraday Highs Compare Brokers The post Dow Inc. Stock Is The Best Bet of the Post-Split Bunch appeared first on InvestorPlace.

  • Reuters11 days ago

    BUZZ-U.S. stocks weekly: Pivot

    ** S&P 500 snaps 4-week losing streak, surges 4.4%. Wall Street rallies Fri on rate cut hopes, trade optimism ** Fed Chair Powell remarks Tues that Fed will act "as appropriate" in face of trade war, other risks; pivot seemingly opens door to possible interest rate cuts ** Indeed, the SPX finds a floor, then builds on its bounce ** This as the DJI turns in its best week of the year , ends longest weekly losing streak since 2011 ** And strength averts a 5-week FANG fumble ** Every sector advances: Materials and tech soar, while communication services lags; tech/growth tries to end its setback vs financials/value ** Materials leap 9.1%. DuPont de Nemours Inc gains 14% after board approves $2 bln stock buyback, and analyst says co one of the best opportunities in chemicals sector ** Tech jumps 6%. Chip stocks rebound as investors breathe life into battered tech shares.

  • Materials ETFs Surge Amid Rate Cut Hopes
    Investopedia11 days ago

    Materials ETFs Surge Amid Rate Cut Hopes

    Basic materials stocks have rallied in the first week of June on dollar weakness. Play for continued strength using these ETFs.

  • Why and Where Dow Inc. Stock Is a Bearish Short
    InvestorPlace12 days ago

    Why and Where Dow Inc. Stock Is a Bearish Short

    When it comes to the new Dow Inc. (NYSE:DOW), you'll hear it's complicated. And it is. That is until investors look at DD stock where the long and short of it merge into a downtrend and a playable bearish position. Let me explain.Source: Shutterstock This past month, DowDupont, one of the world's largest industrial chemical companies, completed some complex financial engineering with a spin-off into three separate publicly traded vehicles. That follows the former company's own existence as the spawn of a tax-saving arrangement a few years ago.Now DowDupont has split into conglomerate-style DuPont (NYSE:DD), agriculture-focused Corteva (NYSE:CTVA) and commodities chemical producer Dow Inc. But management's bright idea to deliver increased shareholder value to its investors -- and likely enrich themselves -- hasn't gone exactly as planned.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFor its part DD stock has enjoyed Wall Street's backing. Shares exploded higher this week following an "overweight" initiation by Morgan Stanley. The firm sees value in DuPont regardless of whether it becomes a "true multi-industry" company or keeps its businesses separated.Meanwhile, shares of CTVA have found less enthusiastic support. Among analysts weighing in, eight of 11 rate Corteva with a hold recommendation and $30 price target. Shares of CTVA were recently trading at $27.50. * 10 Stocks to Buy That Could Be Takeover Targets Okay, but what about DOW stock? On the price chart, shares continue to formulate a downtrend despite decrees that the sum of all those parts should be worth more. They're also looking ready for traders to short DOW sooner rather than later. DOW Stock Daily ChartSince being spun off, DOW stock has worked its way into a downtrend within a simple price channel. Last week's new trading low in shares could ultimately resolve itself as a lower-low or undercut double-bottom pattern relative to Dow's March low. For now, though, DOW remains in control of bears. And currently, shares are in the process of setting up for a lower risk short.This week's rally has pushed DOW stock into an area of resistance. The zone is backed by Dow's channel line, the 38% retracement level and Dow's less-than-receptive debut when trading in DOW stock first commenced, and making shares likely top-heavy with anxious bulls looking to sell.For traders agreeable that a bearish trend in motion can stay in motion in DOW stock, I'd recommend waiting on this week's high to be confirmed as a daily pivot within the existing downtrend. From there, placing a stop above the pattern and taking profits as fresh lows develop looks like a winning strategy off and on the price chart with no complex financial engineering required.Investment accounts under Christopher Tyler's management do not currently own positions in any securities mentioned in this article. The information offered is based upon Christopher Tyler's observations and strictly intended for educational purposes only; the use of which is the responsibility of the individual. . For additional market insights and related musings, follow Chris on Twitter @Options_CAT and StockTwits. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * The 4 FANG Stocks Won't Be Bitten By Regulation Threats * 10 Stocks to Buy That Could Be Takeover Targets * 4 Big Bank Stocks Rebounding Compare Brokers The post Why and Where Dow Inc. Stock Is a Bearish Short appeared first on InvestorPlace.

  • New Strong Sell Stocks for June 6th
    Zacks12 days ago

    New Strong Sell Stocks for June 6th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • Barrons.com14 days ago

    The Difference Between Corteva Stock Bulls and Bears Is Just the Weather

    Wall Street is weighing in on Corteva stock, now that it is a stand alone publicly traded company. The overwhelming opinion of Wall Street is “meh,” with the bears worried about the weather.

  • Reuters15 days ago

    US STOCKS-Wall Street falls as Facebook, Alphabet, Amazon drag

    The three major U.S. stock indexes declined on Monday on weaker-than-expected economic data, while shares of Alphabet, Facebook and Amazon.com fell sharply on fears the companies are the targets of U.S. government antitrust regulators, putting pressure on the tech-laden Nasdaq. The benchmark S&P 500 swung in and out of negative territory as investors also eyed the latest comments around the U.S. trade battles with both China and Mexico as well as U.S. President Donald Trump's decision Friday to end preferential trade treatment for India.

  • DuPont Announces Board Approval of $2 Billion Share Buyback Program and Files Pro Forma Financial Information
    PR Newswire15 days ago

    DuPont Announces Board Approval of $2 Billion Share Buyback Program and Files Pro Forma Financial Information

    WILMINGTON, Del., June 3, 2019 /PRNewswire/ -- DuPont de Nemours, Inc. ("DuPont") today announced that its board of directors approved a $2 billion share buyback program which expires on June 1, 2021. Under the stock buyback program, shares of the company's common stock may be repurchased periodically in open market or private transactions.

  • DuPont Becomes Independent Company, Uniquely Positioned to Drive Innovation-Led Growth and Shareholder Value
    PR Newswire15 days ago

    DuPont Becomes Independent Company, Uniquely Positioned to Drive Innovation-Led Growth and Shareholder Value

    WILMINGTON, Del., June 3, 2019 /PRNewswire/ -- DuPont de Nemours, Inc. ("DuPont"), the premier innovation provider of value-added specialized solutions that transform industries and everyday life, today announced its debut as an independent company following the successful separation of its Agriculture Division through the spin-off of Corteva, Inc. ("Corteva"). "The new DuPont launches today with leading market positions in four core markets and strong geographic, customer and end-market diversification," said Ed Breen, Executive Chairman of DuPont. Marc Doyle, Chief Executive Officer of DuPont, added, "DuPont is uniquely positioned to leverage its balanced portfolio, deep customer relationships, R&D expertise, and competitive operating model to win in the marketplace and drive value for all its stakeholders.

  • DuPont to Present at Bernstein's 35th Annual Strategic Decisions Conference
    PR Newswire20 days ago

    DuPont to Present at Bernstein's 35th Annual Strategic Decisions Conference

    WILMINGTON, Del., May 29, 2019 /PRNewswire/ -- Ed Breen, Executive Chairman-elect of future DuPont, the premier innovation provider of value-added specialized solutions that transform industries and everyday lives, will present today at Bernstein's 35th Annual Strategic Decisions Conference at 9 a.m. ET in New York. In his presentation, Breen will reaffirm financial guidance for the second quarter and full-year 2019 for the Specialty Products Division of DowDuPont ("DuPont"). This morning DuPont also filed a Form 8-K with the U.S. Securities & Exchange Commission announcing non-cash, pre-tax charges in the approximate range of $800 million - $1,300 million in the second quarter 2019 primarily related to impairment testing of goodwill.

  • PR Newswire21 days ago

    Corteva Set to Join S&P 500; Fluor to Join S&P MidCap 400 and Realogy and Bloomin' Brands to Join S&P SmallCap 600

    NEW YORK , May 28, 2019 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P 100, S&P MidCap 400 and S&P SmallCap 600: Corteva Inc. (NYSE: CTVA) ...

  • PR Newswire26 days ago

    DowDuPont Stockholders Approve Reverse Stock Split, Board of Directors Determines Reverse Stock Split Ratio

    WILMINGTON, Del., May 23, 2019 /PRNewswire/ -- DowDuPont Inc. (DWDP) announced at today's Special Meeting of Stockholders that its stockholders approved a reverse stock split of the company's common stock. With approximately 2 billion eligible votes cast, stockholders voted approximately 97 percent in favor of the reverse stock split.

  • China's technology tactics irk its trading partners
    Associated Press29 days ago

    China's technology tactics irk its trading partners

    BEIJING (AP) — For four decades, Beijing has cajoled or pressured foreign companies to hand over technology. And its trading partners say if that didn't work, China stole what it wanted.

  • Moody'slast month

    Dow Chemical Company (The) -- Moody's assigns Baa2 ratings to Dow's new notes; outlook stable

    Moody's Investors Service ("Moody's") assigned Baa2 ratings to unsecured notes to be issued by The Dow Chemical Company. "Dow is taking advantage of relatively low interest rates to refinance its term loan and other near-term maturities," stated John Rogers, Senior Vice President at Moody's and lead analyst on Dow.

  • PR Newswirelast month

    DowDuPont Board of Directors Approves Corteva Distribution and Announces Effectiveness of Form 10 Registration Statement for Corteva

    WILMINGTON, Del., May 7, 2019 /PRNewswire/ -- DowDuPont (DWDP) today announced that its Board of Directors has approved the previously announced separation of DowDuPont's Agriculture Division, which will become Corteva Agriscience™ on June 1, 2019. To effect the separation, the DowDuPont Board of Directors declared a pro rata dividend of all of the outstanding shares of common stock of Corteva, Inc. ("Corteva"). The dividend is expected to be paid on June 1, 2019 to DowDuPont stockholders of record as of the close of business on May 24, 2019, the record date.

  • Moody's2 months ago

    DowDuPont Inc. -- Moody's assigns Prime-2 rating to DowDuPont's commercial paper program

    Rating Action: Moody's assigns Prime-2 rating to DowDuPont's commercial paper program. Global Credit Research- 24 Apr 2019. New York, April 24, 2019-- Moody's Investors Service assigned a Prime-2 rating ...

  • 7 Dental Stocks to Buy That Will Make You Smile
    InvestorPlace2 months ago

    7 Dental Stocks to Buy That Will Make You Smile

    A few years ago I was sitting in the dentist chair for my six-month examination and teeth cleaning. As I stared at the ceiling, I couldn't help notice the name Belmont on the arm of the bright light burning a hole in my retina. I couldn't help myself, asking the dentist if she'd ever invested in a dental-related company? She said she hadn't. "Not even Henry Schein (NASDAQ:HSIC)?", I asked. Nope. That was the end of the investment discussion. Recently, I saw an article that said dental startups such as Candid and Smile Direct Club, which provides systems for mild-to-moderate teeth straightening -- saving you a bundle in the process -- have investors lining up to invest in the private companies. InvestorPlace - Stock Market News, Stock Advice & Trading TipsOf course, that brought me back to that day in the dentist's chair, when I wondered about stocks to buy that will make you smile. * 10 Stocks That Are Screaming Buys Right Now Here are seven names I've identified that will put money in your pockets. Henry Schein (HSIC)Source: Shutterstock If you're a dentist, you've likely got Henry Schein on speed dial. It distributes more than 120,000 branded products and another 180,000 private label products to dentists and medical practitioners. It is the No. 1 global dental distributor and the No. 2 physician and alternate care distributor in the U.S. In fact, 90% of U.S. dental practices are active Schein customers. So, the next time you go to the dentist, be sure to ask how much stuff they buy from the company. It's probably a lot. Things seem to be going smoothly for the Melville, New York, company, yet HSIC is currently trading within 13% of its 52-week low and up less than 5% year-to-date through April 10, one-third the performance of the S&P 500.On three occasions over the past five years, it traded below $55. Within five dollars of doing so a fourth time, HSIC is entering value territory. Fear not. In 2018, Henry Schein's revenues grew by 5.9% year-over-year to $13.2 billion, while its non-GAAP earnings rose 11.4% to $635.3 million, its highest level of sales and profits in its history. Now, exclusively a company dealing with humans after spinning off its animal health business, Henry Schein is ready to take dental to the next level. 3D Systems (DDD)Source: Image via 3D Systems3D Systems (NYSE:DDD) is a 3D printer. Over the past five years as the demand for 3D printing has slowed, so too has the company's revenue and earnings growth. As a result, DDD shares have lost 80% of their value. In 2019, DDD is up more than 7% year-to-date through April 10. However, it lost a great deal of its momentum in March, giving back 23% of its gains on the year. The company's dental segment continues to take a bite out of the competition. It produces dentures, crowns and surgical guides. "There are billions of opportunities here, since virtually anybody could benefit from 3-D printed dental solutions," said CEO Vyomesh Joshi recently. On a non-GAAP basis, 3D Systems went from a $1.7 million loss in 2017 to a $16.5 million gain in 2018 on the strength of a 6% increase in revenue to $688 million. * 10 Dow Jones Stocks Holding the Blue Chip Index Back Trading at 1.8 times revenue, less than half its five-year average price-to-sales ratio, DDD provides investors with an excellent value proposition. Align Technology (ALGN)Source: Shutterstock As dentists go, mine wasn't too pushy about trying the latest and greatest dental product or service, but she sure liked to talk up Invisalign, the $8,000 clear aligner that straightens your teeth. Made by Align Technology (NASDAQ:ALGN), I never took the bait. Now, having moved from Toronto to Halifax over a year ago, and still without a new dentist, I suspect I'll soon be getting the Invisalign sales pitch a second time. Perhaps, startups like Candid are taking a bite out of Align's market share. Given the $4,000 price over 24 months for its teeth alignment product, a good $3,000-$4,000 cheaper than the competition, it's easy to see why. However, I don't think investors should give up on ALGN just yet. As I look at the company's results for 2018, I see a lot of positives.On the top line, revenues grew 34% to $2 billion, a company record, on a 32% increase in Invisalign volume. On the bottom line, net profits were $400.2 million in 2018, 73% higher than a year ago. Forget for a moment that Invisalign didn't exist. Its iTero scanners experienced 68% growth in 2018; iTero's revenues now account for 14% of Align's overall revenue, up 290 basis points from 2017. Trading well off its all-time high of $398.88, investors buying in today, should have significant upside in the months ahead. Dentsply Sirona (XRAY)Source: Shutterstock I first became familiar with Dentsply Sirona (NASDAQ:XRAY) way back in March 2013, more than two years before Dentsply would pay $5.5 billion for Sirona Dental Systems, a company I liked because of its diversified revenue streams. "Sirona's revenue diversification is what makes it such a good company. It generates business from four operating segments: Dental CAD/CAM Systems, Imaging Systems, Treatment Centers, and Instruments," I wrote March 20, 2013. "Its CAD/CAM and Imaging Systems accounted for 70% of its overall revenue in the first quarter ended December 2012."If you took my advice and bought 100 shares of Sirona at the Q2 2013 high of $73.98, today you'd have $9,158, a 24% return. But over three years, it's seen a mediocre 5% return. So, do I still think XRAY is worth holding for the long haul?I do. Here's why.Like most acquisitions, the tie-up didn't go nearly as smoothly as hoped. As a result, the company was forced to implement a turnaround plan that will simplify its business. Where have I heard that before?Anyway, when you bring together two reasonably large businesses, you often lose focus on parts of it and those units suffer. So, it's exiting these businesses and cutting staffing by as much as 8%. By fiscal 2020, analysts expect it to earn $2.64 a share, its best earnings performance since 2016. * The 7 Best Long-Term Stocks for 2019 And Beyond It has had a good run in 2019, up 36% year-to-date. I'd be patient and try to buy on weakness in the mid-$40s. Patterson Companies (PDCO)Source: Shutterstock A little over two years ago, Globe and Mail business reporter Scott Barlow highlighted 12 healthcare stocks that had stable cash flow. He argued that businesses such as Patterson Companies (NASDAQ:PDCO), a distributor of dental and animal health products, would make you rich over the long haul because of this critical attribute. Since the article, PDCO stock has lost approximately half its value. Ouch.However, in the nine months ended Jan. 27, 2019, Patterson's operating cash flow increased 91% to $76.3 million. After subtracting $33.9 million in capital expenditures, it generated free cash flow of $42.4 million or 77% of its net income. On the top line, revenues in the first three quarters of fiscal 2019 barely budged, up 1.8% to $4.14 billion. On the bottom line GAAP basis, its net income fell 69% to $55.2 million. On an adjusted basis, earnings fell 25% to $95.9 million. While this article is about dental businesses, Patterson's animal health business (58% of revenue) continues to provide PDCO with diversified revenue streams that will protect it when the economy turns south because a lot of pet owners won't scrimp on their companion animal's wellbeing. Yielding 4.8% at the moment, it has plenty of free cash flow to keep paying its juicy dividend. If you're an income investor, PDCO is an excellent stock to own before the company's restructuring takes hold. Get paid to wait. Procter & Gamble (PG)Source: Mike Mozart via Flickr (Modified)My old dentist's dental technician recommended that I buy an Oral-B electric toothbrush because it does a better job of brushing your teeth without overdoing it, thus hurting your gums. She was right. Originally invented in 1950 by California periodontist Dr. Robert Hutson, he sold the company to Cooper Laboratories, who in turn sold it to Gillette in 1984 for $188.5 million. The rest, as they say, is history. On April 9, Oral-B's owner, Procter & Gamble (NYSE:PG), raised its quarterly dividend by 4% to 74.59 cents a share, an annualized rate of $2.98, yielding 2.8% despite a 37% gain over the past 52 weeks. This is P&G's 63rd consecutive year increasing its dividend. Oral-B and the rest of its oral care brands generated 9% of P&Gs revenue in the second quarter. Part of the healthcare segment, sales and earnings were both up slightly in the first quarter, delivering solid if not spectacular results. * The 10 Fastest-Growing Stocks to Invest In Right Now Consider Oral-B the company's slow-growth business. Overall, however, Procter & Gamble is doing just fine. Church & Dwight (CHD) Source: slgckgc via Flickr (Modified)Church & Dwight (NYSE:CHD) is a smaller version of P&G. But make no mistake, it competes with the best of them. As far as dental care goes, it has Arm & Hammer, AIM, Close-Up and Pepsodent toothpaste. Other brands include Orajel and Waterpik. The company has become adept at making smaller acquisitions and then growing those businesses over time. Most recently, it announced it had acquired two hair removal brands, Flawless and Finishing Touch, for $475 million and a further $425 million in potential earnouts. The two brands add $180 million in annual revenue and $55 million in EBITDA.The owners of Flawless would have been wise to ask for stock instead of cash because over the past decade, CHD stock has delivered an annualized total return of 19.4%, almost double P&G.As stocks go, CHD is a perfect 10. I urge you to check it out. At the time of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post 7 Dental Stocks to Buy That Will Make You Smile appeared first on InvestorPlace.

  • DuPont Breaks Ground on New European Headquarters for Industrial Biosciences in the Netherlands
    PR Newswire5 months ago

    DuPont Breaks Ground on New European Headquarters for Industrial Biosciences in the Netherlands

    LEIDEN, Netherlands, Jan. 24, 2019 /PRNewswire/ -- DuPont Industrial Biosciences officially broke ground today on its new site at the Leiden Bio Science Park in Oegstgeest, the Netherlands. The state-of-the-art, multidisciplinary facility will utilize the tools of modern biotechnology to make industrial processes more efficient and products more sustainable.

  • Moody's7 months ago

    DowDuPont Inc. -- Moody's assigns Baa1 to DowDuPont notes

    Moody's Investors Service ("Moody's") assigned Baa1 ratings to the debt of DowDuPont Inc. ("New DuPont"). "Notwithstanding the lack of robust public financials for the New DuPont, we expect the company to generate over $1.5 billion of free cash flow in 2019 on a pro forma basis and upwards of $2 billion thereafter", stated John Rogers, Senior Vice President at Moody's and lead analyst on the New DuPont. Baa2 stable) and Corteva, and is expected to be renamed DuPont Inc. in 2019.

  • Moody's7 months ago

    E.I. du Pont de Nemours and Company -- Moody's affirms DuPont's A3 ratings, changes outlook to stable

    Moody's Investors Service ("Moody's") affirmed the A3 and Prime-2 ratings of E.I. du Pont de Nemours and Company (DuPont) and changed the outlook on the ratings to stable from negative. The action is in response to the company's disclosure of its plan for the balance sheet of DuPont, which is expected to become wholly owned by a new legal entity, Corteva, Inc. On June 1st, 2019, Corteva Inc. (Corteva) is expected to be spun off from DowDuPont, and any existing rated debt of DuPont will become the obligations of Corteva.

  • Moody's7 months ago

    Brazoria County Brazos River Hrbr. Nav. Dist. -- Moody's affirms Dow's Baa2 rating; outlook stable

    Moody's Investors Service ("Moody's") affirmed the Baa2 ratings of The Dow Chemical Company, its Prime-2 rating for commercial paper and its stable outlook. This follows the disclosure that Dow will have roughly $16 billion of balance sheet debt once it is spun-out from DowDuPont, Inc. (Baa1 stable) in April 2019. "While Dow's reduction in balance sheet debt and pension liabilities will be significant, after adjusting for the earnings from businesses transferred to Corteva and the New DuPont, credit metrics will not improve enough to support a higher rating," stated John Rogers, Senior Vice President at Moody's and lead analyst on Dow.

  • Moody's7 months ago

    DowDuPont Inc. -- Moody's assigns Baa1 to DowDuPont; outlook stable

    Moody's Investors Service ("Moody's") assigned first-time issuer rating of Baa1 to DowDuPont Inc. ("New DuPont"). DowDuPont Inc. is expected to be renamed DuPont Inc. in 2019. Assets and businesses that will become the New DuPont are expected to be transferred from Dow and the current DuPont operations prior to their spin-outs.

  • Corteva Agriscience (CTVA) makes mark a independent company from DowDuPont
    Yahoo Finance Video15 days ago

    Corteva Agriscience (CTVA) makes mark a independent company from DowDuPont

    Corteva Agriscience CEO Jim Collins joins Yahoo Finance's Adam Shapiro, Julie Hyman, and Brian Sozzi to discuss the company's official separation from DowDuPont and the state of the global agriculture market.